Hsbc Holdings PLC raised its stake in agilon health, inc. (NYSE:AGL - Free Report) by 205.3% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 132,952 shares of the company's stock after buying an additional 89,407 shares during the period. Hsbc Holdings PLC's holdings in agilon health were worth $249,000 as of its most recent filing with the SEC.
A number of other hedge funds and other institutional investors have also modified their holdings of AGL. Vanguard Group Inc. lifted its stake in agilon health by 0.9% during the fourth quarter. Vanguard Group Inc. now owns 31,112,407 shares of the company's stock valued at $59,114,000 after buying an additional 272,787 shares in the last quarter. Capital International Investors lifted its position in shares of agilon health by 72.0% in the 4th quarter. Capital International Investors now owns 22,331,873 shares of the company's stock valued at $42,431,000 after acquiring an additional 9,346,295 shares in the last quarter. Geode Capital Management LLC boosted its stake in agilon health by 0.5% in the 4th quarter. Geode Capital Management LLC now owns 6,928,724 shares of the company's stock worth $13,168,000 after purchasing an additional 35,207 shares during the period. Charles Schwab Investment Management Inc. raised its stake in agilon health by 49.2% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 4,541,549 shares of the company's stock valued at $8,629,000 after purchasing an additional 1,498,524 shares during the period. Finally, JPMorgan Chase & Co. lifted its holdings in shares of agilon health by 326.4% in the third quarter. JPMorgan Chase & Co. now owns 1,415,419 shares of the company's stock valued at $5,563,000 after purchasing an additional 1,083,492 shares in the last quarter.
Analyst Ratings Changes
Several analysts recently commented on the stock. The Goldman Sachs Group raised their price target on shares of agilon health from $2.50 to $5.00 and gave the stock a "neutral" rating in a report on Thursday, May 8th. TD Cowen increased their target price on shares of agilon health from $3.50 to $6.00 and gave the stock a "hold" rating in a research report on Tuesday, April 15th. Stifel Nicolaus boosted their price target on shares of agilon health from $2.00 to $3.00 and gave the company a "hold" rating in a report on Wednesday, February 26th. Robert W. Baird cut their price objective on agilon health from $6.00 to $5.00 and set a "neutral" rating for the company in a report on Tuesday, April 15th. Finally, Barclays lifted their price objective on agilon health from $2.00 to $3.00 and gave the company an "underweight" rating in a research report on Thursday, May 8th. Two research analysts have rated the stock with a sell rating, thirteen have given a hold rating and five have given a buy rating to the company's stock. According to data from MarketBeat, agilon health currently has an average rating of "Hold" and an average price target of $4.90.
Get Our Latest Stock Report on agilon health
agilon health Stock Performance
AGL traded down $0.17 during trading on Thursday, hitting $2.51. The stock had a trading volume of 1,954,274 shares, compared to its average volume of 4,881,272. The firm has a market cap of $1.04 billion, a PE ratio of -2.63 and a beta of 0.38. The company has a current ratio of 1.29, a quick ratio of 1.29 and a debt-to-equity ratio of 0.06. agilon health, inc. has a 12 month low of $1.50 and a 12 month high of $7.73. The company has a 50 day simple moving average of $4.23 and a 200-day simple moving average of $3.19.
agilon health (NYSE:AGL - Get Free Report) last posted its quarterly earnings data on Tuesday, May 6th. The company reported $0.03 EPS for the quarter, topping analysts' consensus estimates of ($0.01) by $0.04. The business had revenue of $1.53 billion for the quarter, compared to analyst estimates of $1.50 billion. agilon health had a negative return on equity of 47.84% and a negative net margin of 6.88%. The firm's revenue for the quarter was down 4.5% on a year-over-year basis. During the same period in the previous year, the company posted ($0.02) earnings per share. Analysts expect that agilon health, inc. will post -0.59 EPS for the current year.
agilon health Profile
(
Free Report)
agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.
Read More

Before you consider agilon health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and agilon health wasn't on the list.
While agilon health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.